Albert Koong, MD, PhD, becomes the new Chief Scientific Officer at UT MD Anderson Cancer Center.
Key Details
- 1Albert Koong, MD, PhD, formally appointed as UT MD Anderson's Chief Scientific Officer effective June 1, 2026.
- 2Previously served as interim CSO since January 1, 2026.
- 3Role includes overseeing laboratory and clinical research, fostering innovation, and supporting AI-driven scientific advancement.
- 4Has led as division head of Radiation Oncology and contributed significantly to GI radiation oncology research.
- 5Recognized with honors such as Fellow of the American College of Radiology (FACR) and American Society for Radiation Oncology (FASTRO).
Why It Matters
Leadership at a prominent cancer center, especially with expertise in radiation oncology and ties to AI advancement, influences radiology and imaging research directions and collaborations. This appointment further signals ongoing integration of AI in cancer science by institutional leaders.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI Model Accelerates Accurate Dose Prediction for CyberKnife Radiotherapy
A physics- and spatially informed diffusion model accelerates Monte Carlo–level dose estimation for CyberKnife radiotherapy using planning CT and anatomical data.